This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zecchini, S. Articles by Cavallaro, U. Search for Related Content PubMed PubMed Citation Articles by Zecchini, S. Articles by Cavallaro, U.

The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium

¹ FIRC Institute of Molecular Oncology, ² European Institute of Oncology, and ³ University of Milano School of Medicine, Milano, Italy; ⁴ Department of Pathology, The University of Texas M. D. Anderson Cancer, Houston, Texas; ⁵ Wistar Institute and ⁶ Fox Chase Cancer Center, Philadelphia, Pennsylvania

Requests for reprints: Ugo Cavallaro, FIRC Institute of Molecular Oncology, via Adamello 16, I-20139 Milano, Italy. Phone: 39-02-574303-224; Fax: 39-02-574303-244; E-mail: ugo.cavallaro{at}ifom-ieo-campus.it.

Key Words: L1 cell adhesion molecule • ovarian surface epithelium • ovarian carcinoma • fibroblast growth factor receptor • cancer progression

Epithelial ovarian carcinoma (EOC) arises from the ovarian surface epithelium (OSE), a monolayer of poorly differentiated epithelial cells that lines the ovary. The molecular mechanisms underlying EOC invasion into the surrounding stroma and dissemination to the peritoneum and to retroperitoneal lymph nodes are still unclear. Here, we analyzed the expression and the functional role of the cell adhesion molecule L1 during EOC development. In patient-derived samples, L1 was expressed both in OSE and in a subset of EOC, in the latter being mostly restricted to the invasive areas of the tumors. The expression of L1 correlated significantly with poor outcome and with unfavorable clinicopathologic features of the disease. The peculiar expression pattern of L1 in normal OSE and invasive EOC raised the possibility that this adhesion molecule serves a different function in nontransformed versus neoplastic ovarian epithelial cells. Indeed, we showed that in OSE cells L1 supports cell-cell adhesion and enhances apoptosis, whereas it has no effect on cell proliferation and invasion. In contrast, L1 inhibits cell-cell adhesion and apoptosis in ovarian carcinoma cells, where it promotes malignancy-related properties, such as cell proliferation, Erk1/2-dependent and phosphoinositide 3-kinase–dependent invasion, and transendothelial migration. Interestingly, a crosstalk with the fibroblast growth factor receptor signaling is implicated in the promalignant function of L1 in tumor cells. Our findings point to L1 as an EOC biomarker correlating with poor prognosis, and highlight a switch in L1 function associated to the neoplastic transformation of ovarian epithelial cells, thus implicating L1 as a potential therapeutic target. [Cancer Res 2008;68(4):1110–8]

This article has been cited by other articles:

				M. HEUBNER, P. WIMBERGER, S. KASIMIR-BAUER, F. OTTERBACH, R. KIMMIG, and W. SIFFERT The AA Genotype of a L1C G842A Polymorphism Is Associated with an Increased Risk for Ovarian Cancer Anticancer Res, August 1, 2009; 29(8): 3449 - 3452. [Abstract] [Full Text] [PDF]

				L. Maddaluno, S. E. Verbrugge, C. Martinoli, G. Matteoli, A. Chiavelli, Y. Zeng, E. D. Williams, M. Rescigno, and U. Cavallaro The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells J. Exp. Med., March 16, 2009; 206(3): 623 - 635. [Abstract] [Full Text] [PDF]